Can DHEA Cause Heart Palpitations?

No large human trial has established that DHEA supplementation directly causes heart palpitations, but the hormone has real effects on calcium channels and catecholamine signaling that make a connection biologically plausible. DHEA (dehydroepiandrosterone) is a steroid hormone produced mainly by the adrenal glands, and it serves as a precursor to both testosterone and estrogen. Because it touches multiple hormonal and electrical pathways in the body, the relationship between DHEA and heart rhythm is more complicated than a simple yes-or-no answer.

What DHEA Actually Does in the Body

DHEA is one of the most abundant steroid hormones circulating in the blood. It is produced primarily in the adrenal cortex, with smaller amounts made in other tissues, and it functions as a building block that the body converts into sex hormones like testosterone and estrogen depending on what is needed.¹ DHEA levels peak in your twenties and then decline steadily with age, dropping by roughly 80 percent by the time you reach your seventies. This decline, sometimes called “adrenopause,” is one reason DHEA supplements have been marketed so aggressively as an anti-aging remedy.²

Whether its effects lean estrogenic or androgenic depends on the hormonal environment in each person. In someone whose testosterone is low, DHEA conversion tends to push toward androgens. In someone already producing plenty of androgens, the balance may shift toward estrogenic effects.³ This variability matters for understanding why two people taking the same dose can experience very different side effects, including cardiac symptoms.

How DHEA Interacts with the Heart’s Electrical System

Your heartbeat is governed by the flow of ions, especially calcium, through specialized channels in heart muscle cells. When calcium enters these cells in an orderly fashion, you get a steady rhythm. When the flow is disrupted, the rhythm can become irregular, and you may feel that as palpitations, skipped beats, or a racing heart.

Laboratory studies have shown that DHEA directly affects two types of calcium channels relevant to heart rhythm. One study using patch-clamp electrophysiology found that DHEA inhibits T-type calcium channels at concentrations in the low-micromolar range, and it shifts the electrical properties of these channels toward a state where they are less likely to open.⁴ T-type channels play a role in pacemaker activity, so suppressing them could, in theory, alter heart rate or rhythm in ways that some people feel as palpitations.

A separate line of research looked at epiandrosterone, a metabolite the body produces when it processes DHEA. Epiandrosterone was found to block L-type calcium channels in ventricular heart cells in a dose-dependent and reversible way, acting similarly to a class of blood-pressure drugs called dihydropyridine calcium channel blockers.⁵ L-type channels are responsible for the strong contraction of the heart muscle. Inhibiting them reduces how forcefully the heart contracts, which some people might perceive as a change in their heartbeat.

These are cell and tissue studies, not human clinical trials, so they show what DHEA and its metabolites are capable of doing to cardiac cells in isolation. Whether these effects occur at the doses people typically take as supplements is harder to say, but the mechanisms are real.

The Catecholamine Question

Catecholamines are the “fight or flight” hormones, including adrenaline (epinephrine), noradrenaline (norepinephrine), and dopamine. A surge of catecholamines makes your heart pound, so any substance that changes catecholamine release could plausibly trigger palpitations.

The evidence on DHEA and catecholamines points in two directions, which is part of why this topic remains unsettled. One study using bovine adrenal cells found that DHEA actually inhibited catecholamine secretion, suppressing the calcium signals that trigger the release process.⁶ That would suggest DHEA should calm the heart, not rev it up.

But a different study found that DHEA-S, the sulfated form of DHEA that circulates in much higher concentrations in the blood, acutely and dose-dependently increased catecholamine levels, including norepinephrine and dopamine. The effect peaked within about 10 to 30 minutes and appeared to work through a fast-acting cellular mechanism involving the structural scaffolding inside the cell.⁷

How do you reconcile these? The two studies used different cell types, different forms of the hormone (DHEA vs. DHEA-S), and different experimental conditions. In the living human body, both forms are present and interconvert, and the net effect on catecholamine release likely depends on the dose, the tissue, and the individual’s hormonal baseline. But the key takeaway is that DHEA-family steroids are not inert when it comes to adrenaline-like hormones, and that makes a catecholamine-driven palpitation mechanism at least plausible.

What High Doses Do in Animal Models

Most human supplementation studies use doses in the range of 25 to 50 milligrams per day, but some people self-prescribe far higher amounts. Animal research offers a window into what happens at extreme doses. In one study, rats given high-dose DHEA over 90 days developed mild but visible heart tissue changes, including misshapen cell nuclei, disorganized muscle fibers, and signs of inflammation.⁸ These are structural changes rather than rhythm disturbances per se, but inflamed or disorganized heart tissue is a well-known substrate for arrhythmias. The doses used in that study were far above typical human supplementation levels, so the finding is more of a cautionary signal than a direct prediction of what happens at standard doses.

It is worth noting that DHEA’s broader cardiovascular profile in animal research is actually more protective than harmful. In studies of ovariectomized rats (used to model postmenopausal hormone loss), DHEA treatment improved blood vessel relaxation and reduced oxidative stress, essentially reversing some of the vascular damage caused by hormone depletion.⁹ A review of DHEA’s cardiovascular mechanisms concluded that it generally acts as a vasorelaxant and anti-remodeling agent.¹⁰ So DHEA is not a straightforward cardiotoxin. The picture that emerges is a hormone that is broadly cardiovascular-friendly at moderate levels but may cross into problematic territory when doses are high or when the hormonal conversion products accumulate in certain individuals.

Hormonal Conversion and Its Downstream Effects

One of the trickier aspects of DHEA supplementation is that you are not just adding DHEA to your system. Your body converts it into testosterone, estrogen, and other metabolites, and each of those downstream hormones has its own effects on the heart. Excess testosterone, for example, has been associated with increased red blood cell production (which can thicken the blood) and changes in cardiac repolarization that predispose some individuals to arrhythmias. Elevated estrogen levels can also influence cardiac ion channels and autonomic nervous system tone.

Because DHEA’s conversion pathway depends on the existing hormonal milieu, the same dose can produce quite different hormonal end products in different people.³ A postmenopausal woman and a young man taking the same 50-milligram dose are feeding different enzymatic machinery and will end up with different ratios of testosterone to estrogen. This makes it extremely difficult to predict who might develop palpitations and who will not. It also means that published average effects from clinical trials may not reflect what happens to you specifically.

The Supplement Quality Problem

Before assuming that DHEA itself is responsible for any cardiac symptom, it is worth considering what else might be in the bottle. DHEA is sold as a dietary supplement in the United States, which means it does not undergo the same quality controls as prescription medications. Independent testing of sports nutritional supplements has found that some products contain prohibited substances such as ephedrine, caffeine, or undeclared steroids that were not listed on the label.¹¹

Caffeine and ephedrine are both well-established triggers for palpitations. If a DHEA supplement is contaminated with either, a person might attribute the resulting heart symptoms to DHEA itself when the real culprit is an unlisted stimulant. This does not mean DHEA is innocent of all cardiac effects, but it does mean that anecdotal reports of “DHEA gave me palpitations” need to be interpreted cautiously. The supplement industry’s loose labeling standards add a layer of uncertainty that does not exist with pharmaceutical-grade hormones.

DHEA and Vascular Health

While the palpitation question tends to dominate internet searches about DHEA and the heart, the broader cardiovascular evidence paints a more nuanced picture. Several studies suggest that adequate DHEA levels are associated with healthier blood vessels. In a small controlled trial of men, low-dose DHEA supplementation for 12 weeks significantly improved flow-mediated dilation of the brachial artery, a standard measure of how well blood vessels relax. The effect roughly doubled from baseline and was accompanied by improvements in insulin sensitivity.¹²

In postmenopausal women with coronary risk factors, higher circulating DHEA-S levels were independently correlated with better endothelial function, even after accounting for age, body mass, blood pressure, cholesterol, and smoking.¹³ And in a large study of elderly men, DHEA levels predicted the five-year risk of coronary heart disease events, with lower levels associated with higher risk, even after adjusting for traditional cardiovascular risk factors and other hormones.¹⁴

These findings do not mean DHEA supplements prevent heart disease. Observational associations between natural DHEA levels and cardiovascular outcomes could reflect overall health and adrenal function rather than a causal protective effect. But they do suggest that the hormone is not a straightforward cardiac villain, which makes the palpitation question harder to answer definitively.

Who Should Be Most Cautious

If you are taking DHEA and experiencing palpitations, several factors are worth considering before blaming or exonerating the supplement:

• Dose: Self-prescribers sometimes take 100 milligrams or more per day, well above the 25 to 50 milligram range used in most clinical studies. Higher doses produce more downstream hormonal conversion products and are more likely to push calcium channel effects or catecholamine shifts into perceptible territory.
• Sex and hormonal status: Because DHEA converts to both androgens and estrogens, the cardiac impact depends heavily on your existing hormonal balance. Postmenopausal women may experience more estrogenic effects, while men may see androgen-related changes. Either shift can influence heart rhythm.
• Other supplements or medications: DHEA interacts with a range of drugs and hormones. If you are also taking thyroid medication, stimulants, or other hormonal supplements, the combined effect on cardiac rhythm could be additive in ways that DHEA alone would not produce.
• Pre-existing cardiac conditions: People with known arrhythmias, prolonged QT interval, or structural heart disease are more sensitive to anything that alters calcium channel function or catecholamine levels. For these individuals, even modest effects from DHEA could cross the threshold into symptomatic palpitations.

Any new or worsening palpitations, regardless of suspected cause, warrant a conversation with a doctor rather than simply stopping or continuing the supplement on your own. An electrocardiogram can quickly distinguish between benign awareness of your heartbeat and something that needs attention.

The Marketing and Regulation Gap

DHEA occupies an unusual regulatory space. In the United States, it is sold over the counter as a dietary supplement, while in many other countries it is classified as a controlled substance or prescription medication. The supplement’s popularity exploded in the 1990s when animal research on aging sparked headlines about a “superhormone” that could reverse the clock. Those early animal findings were extrapolated far beyond what the evidence supported, and aggressive marketing turned DHEA into an anti-aging staple.²

The gap between marketing claims and clinical evidence remains wide. While DHEA has shown legitimate benefits in specific populations, such as women with adrenal insufficiency or certain autoimmune conditions, the broad anti-aging narrative has outpaced the science.³ The supplement’s easy availability means that many people take it without medical oversight, at doses chosen from internet forums rather than clinical data, and without baseline or follow-up hormone testing that would reveal whether their bodies are converting the extra DHEA into something problematic. This self-prescribing culture makes it harder to track and study side effects like palpitations, because the people most likely to experience unusual effects are also the least likely to be monitored.

Why Definitive Evidence Is Hard to Come By

The gap in the evidence is partly a design problem. Most DHEA clinical trials have been small, short, and focused on outcomes like quality of life, bone density, or sexual function rather than cardiac rhythm. Palpitations, if recorded at all, typically appear as one line in a safety table rather than as a primary endpoint. Large cardiovascular outcome trials of the kind that established the risks of other hormone therapies have never been done for DHEA. The observational data linking DHEA levels to cardiovascular outcomes point in a generally favorable direction, but they cannot answer the specific question of whether a supplement pill causes an occasional skipped beat.

The cell-level evidence for calcium channel and catecholamine effects is solid within its own context, but translating from a patch-clamp recording on isolated cells to what happens in a whole person with a functioning nervous system, a liver metabolizing the drug, and a complex hormonal background is a big leap. The honest answer is that DHEA can affect the electrical machinery of the heart in laboratory conditions, the downstream hormones it converts into can also alter cardiac rhythm, and contaminated supplements add yet another variable. Whether these effects combine to produce clinically meaningful palpitations in any given person remains a question the research has not clearly resolved.